Compare ALGN & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGN | CHRW |
|---|---|---|
| Founded | 1997 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 17.7B |
| IPO Year | N/A | 1997 |
| Metric | ALGN | CHRW |
|---|---|---|
| Price | $157.47 | $156.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 22 |
| Target Price | ★ $190.50 | $137.86 |
| AVG Volume (30 Days) | ★ 1.6M | 1.4M |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 1.60% |
| EPS Growth | N/A | ★ 70.68 |
| EPS | ★ 5.16 | 4.94 |
| Revenue | $3,982,622,000.00 | ★ $16,504,785,000.00 |
| Revenue This Year | $2.58 | N/A |
| Revenue Next Year | $3.41 | $3.08 |
| P/E Ratio | ★ $30.45 | $31.86 |
| Revenue Growth | ★ 0.56 | N/A |
| 52 Week Low | $122.00 | $84.68 |
| 52 Week High | $246.19 | $162.79 |
| Indicator | ALGN | CHRW |
|---|---|---|
| Relative Strength Index (RSI) | 73.38 | 62.89 |
| Support Level | $144.00 | $158.37 |
| Resistance Level | $152.99 | $162.79 |
| Average True Range (ATR) | 4.97 | 3.24 |
| MACD | 1.74 | -0.36 |
| Stochastic Oscillator | 92.40 | 60.86 |
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.